Level/ Type | Code | Display Name | Code System |
---|
0‑L | 01 | diphtheria, tetanus toxoids and pertussis vaccine | Vaccine Administered |
0‑L | 02 | poliovirus vaccine, live, oral | Vaccine Administered |
0‑L | 03 | measles, mumps and rubella virus vaccine | Vaccine Administered |
0‑L | 04 | measles and rubella virus vaccine | Vaccine Administered |
0‑L | 05 | measles virus vaccine | Vaccine Administered |
0‑L | 06 | rubella virus vaccine | Vaccine Administered |
0‑L | 07 | mumps virus vaccine | Vaccine Administered |
0‑L | 08 | hepatitis B vaccine, pediatric or pediatric/adolescent dosage | Vaccine Administered |
0‑L | 09 | tetanus and diphtheria toxoids, adsorbed, for adult use | Vaccine Administered |
0‑L | 10 | poliovirus vaccine, inactivated | Vaccine Administered |
0‑L | 100 | pneumococcal conjugate vaccine, 7 valent | Vaccine Administered |
0‑L | 101 | typhoid Vi capsular polysaccharide vaccine | Vaccine Administered |
0‑L | 102 | DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine | Vaccine Administered |
0‑L | 103 | meningococcal C conjugate vaccine | Vaccine Administered |
0‑L | 104 | hepatitis A and hepatitis B vaccine | Vaccine Administered |
0‑L | 105 | vaccinia (smallpox) vaccine, diluted | Vaccine Administered |
0‑L | 106 | diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens | Vaccine Administered |
0‑L | 107 | diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation | Vaccine Administered |
0‑L | 108 | meningococcal ACWY vaccine, unspecified formulation | Vaccine Administered |
0‑L | 109 | pneumococcal vaccine, unspecified formulation | Vaccine Administered |
0‑L | 11 | pertussis vaccine | Vaccine Administered |
0‑L | 110 | DTaP-hepatitis B and poliovirus vaccine | Vaccine Administered |
0‑L | 111 | influenza virus vaccine, live, attenuated, for intranasal use | Vaccine Administered |
0‑L | 112 | tetanus toxoid, unspecified formulation | Vaccine Administered |
0‑L | 113 | tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use | Vaccine Administered |
0‑L | 114 | meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P) | Vaccine Administered |
0‑L | 115 | tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed | Vaccine Administered |
0‑L | 116 | rotavirus, live, pentavalent vaccine | Vaccine Administered |
0‑L | 117 | varicella zoster immune globulin (Investigational New Drug) | Vaccine Administered |
0‑L | 118 | human papilloma virus vaccine, bivalent | Vaccine Administered |
0‑L | 119 | rotavirus, live, monovalent vaccine | Vaccine Administered |
0‑L | 12 | diphtheria antitoxin | Vaccine Administered |
0‑L | 120 | diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) | Vaccine Administered |
0‑L | 121 | zoster vaccine, live | Vaccine Administered |
0‑L | 122 | rotavirus vaccine, unspecified formulation | Vaccine Administered |
0‑L | 123 | influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile) | Vaccine Administered |
0‑L | 125 | Novel Influenza-H1N1-09, live virus for nasal administration | Vaccine Administered |
0‑L | 126 | Novel influenza-H1N1-09, preservative-free, injectable | Vaccine Administered |
0‑L | 127 | Novel influenza-H1N1-09, injectable | Vaccine Administered |
0‑L | 128 | Novel influenza-H1N1-09, all formulations | Vaccine Administered |
0‑L | 129 | Japanese Encephalitis vaccine, unspecified formulation | Vaccine Administered |
0‑L | 13 | tetanus immune globulin | Vaccine Administered |
0‑L | 130 | Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated | Vaccine Administered |
0‑L | 131 | Historical record of a typhus vaccination | Vaccine Administered |
0‑L | 132 | Historical record of vaccine containing * diphtheria, tetanus toxoids and acellular pertussis, * poliovirus, inactivated, * Haemophilus influenzae type b conjugate, * Hepatitis B | Vaccine Administered |
0‑L | 133 | pneumococcal conjugate vaccine, 13 valent | Vaccine Administered |
0‑L | 134 | Japanese Encephalitis vaccine for intramuscular administration | Vaccine Administered |
0‑L | 135 | influenza, high dose seasonal, preservative-free | Vaccine Administered |
0‑L | 136 | meningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O) | Vaccine Administered |
0‑L | 137 | HPV, unspecified formulation | Vaccine Administered |
0‑L | 138 | tetanus and diphtheria toxoids, not adsorbed, for adult use | Vaccine Administered |
0‑L | 139 | Td(adult) unspecified formulation | Vaccine Administered |
0‑L | 14 | immune globulin, unspecified formulation | Vaccine Administered |
0‑L | 140 | Influenza, seasonal, injectable, preservative free | Vaccine Administered |
0‑L | 141 | Influenza, seasonal, injectable | Vaccine Administered |
0‑L | 142 | tetanus toxoid, not adsorbed | Vaccine Administered |
0‑L | 143 | Adenovirus, type 4 and type 7, live, oral | Vaccine Administered |
0‑L | 144 | seasonal influenza, intradermal, preservative free | Vaccine Administered |
0‑L | 145 | respiratory syncytial virus monoclonal antibody (motavizumab), intramuscular | Vaccine Administered |
0‑L | 146 | Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine. | Vaccine Administered |
0‑L | 147 | Meningococcal, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135) | Vaccine Administered |
0‑L | 148 | Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine | Vaccine Administered |
0‑L | 149 | influenza, live, intranasal, quadrivalent | Vaccine Administered |
0‑L | 15 | influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE | Vaccine Administered |
0‑L | 150 | Influenza, injectable, quadrivalent, preservative free | Vaccine Administered |
0‑L | 151 | influenza nasal, unspecified formulation | Vaccine Administered |
0‑L | 152 | Pneumococcal Conjugate, unspecified formulation | Vaccine Administered |
0‑L | 153 | Influenza, injectable, Madin Darby Canine Kidney, preservative free | Vaccine Administered |
0‑L | 155 | Seasonal, trivalent, recombinant, injectable influenza vaccine, preservative free | Vaccine Administered |
0‑L | 156 | Rho(D) Immune globulin- IV or IM | Vaccine Administered |
0‑L | 157 | Rho(D) Immune globulin - IM | Vaccine Administered |
0‑L | 158 | influenza, injectable, quadrivalent, contains preservative | Vaccine Administered |
0‑L | 159 | Rho(D) Unspecified formulation | Vaccine Administered |
0‑L | 16 | influenza virus vaccine, whole virus | Vaccine Administered |
0‑L | 160 | Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013 | Vaccine Administered |
0‑L | 161 | Influenza, injectable,quadrivalent, preservative free, pediatric | Vaccine Administered |
0‑L | 162 | meningococcal B vaccine, fully recombinant | Vaccine Administered |
0‑L | 163 | meningococcal B vaccine, recombinant, OMV, adjuvanted | Vaccine Administered |
0‑L | 164 | meningococcal B, unspecified formulation | Vaccine Administered |
0‑L | 165 | Human Papillomavirus 9-valent vaccine | Vaccine Administered |
0‑L | 166 | influenza, intradermal, quadrivalent, preservative free, injectable | Vaccine Administered |
0‑L | 17 | Haemophilus influenzae type b vaccine, conjugate unspecified formulation | Vaccine Administered |
0‑L | 18 | rabies vaccine, for intramuscular injection | Vaccine Administered |
0‑L | 19 | Bacillus Calmette-Guerin vaccine | Vaccine Administered |
0‑L | 20 | diphtheria, tetanus toxoids and acellular pertussis vaccine | Vaccine Administered |
0‑L | 21 | varicella virus vaccine | Vaccine Administered |
0‑L | 22 | DTP-Haemophilus influenzae type b conjugate vaccine | Vaccine Administered |
0‑L | 23 | plague vaccine | Vaccine Administered |
0‑L | 24 | anthrax vaccine | Vaccine Administered |
0‑L | 25 | typhoid vaccine, live, oral | Vaccine Administered |
0‑L | 26 | cholera vaccine | Vaccine Administered |
0‑L | 27 | botulinum antitoxin | Vaccine Administered |
0‑L | 28 | diphtheria and tetanus toxoids, adsorbed for pediatric use | Vaccine Administered |
0‑L | 29 | cytomegalovirus immune globulin, intravenous | Vaccine Administered |
0‑L | 30 | hepatitis B immune globulin | Vaccine Administered |
0‑L | 31 | hepatitis A vaccine, pediatric dosage, unspecified formulation | Vaccine Administered |
0‑L | 32 | meningococcal polysaccharide vaccine (MPSV4) | Vaccine Administered |
0‑L | 33 | pneumococcal polysaccharide vaccine, 23 valent | Vaccine Administered |
0‑L | 34 | rabies immune globulin | Vaccine Administered |
0‑L | 35 | tetanus toxoid, adsorbed | Vaccine Administered |
0‑L | 36 | varicella zoster immune globulin | Vaccine Administered |
0‑L | 37 | yellow fever vaccine | Vaccine Administered |
0‑L | 38 | rubella and mumps virus vaccine | Vaccine Administered |
0‑L | 39 | Japanese Encephalitis Vaccine SC | Vaccine Administered |
0‑L | 40 | rabies vaccine, for intradermal injection | Vaccine Administered |
0‑L | 41 | typhoid vaccine, parenteral, other than acetone-killed, dried | Vaccine Administered |
0‑L | 42 | hepatitis B vaccine, adolescent/high risk infant dosage | Vaccine Administered |
0‑L | 43 | hepatitis B vaccine, adult dosage | Vaccine Administered |
0‑L | 44 | hepatitis B vaccine, dialysis patient dosage | Vaccine Administered |
0‑L | 45 | hepatitis B vaccine, unspecified formulation | Vaccine Administered |
0‑L | 46 | Haemophilus influenzae type b vaccine, PRP-D conjugate | Vaccine Administered |
0‑L | 47 | Haemophilus influenzae type b vaccine, HbOC conjugate | Vaccine Administered |
0‑L | 48 | Haemophilus influenzae type b vaccine, PRP-T conjugate | Vaccine Administered |
0‑L | 49 | Haemophilus influenzae type b vaccine, PRP-OMP conjugate | Vaccine Administered |
0‑L | 50 | DTaP-Haemophilus influenzae type b conjugate vaccine | Vaccine Administered |
0‑L | 51 | Haemophilus influenzae type b conjugate and Hepatitis B vaccine | Vaccine Administered |
0‑L | 52 | hepatitis A vaccine, adult dosage | Vaccine Administered |
0‑L | 53 | typhoid vaccine, parenteral, acetone-killed, dried (U.S. military) | Vaccine Administered |
0‑L | 54 | adenovirus vaccine, type 4, live, oral | Vaccine Administered |
0‑L | 55 | adenovirus vaccine, type 7, live, oral | Vaccine Administered |
0‑L | 62 | human papilloma virus vaccine, quadrivalent | Vaccine Administered |
0‑L | 66 | Lyme disease vaccine | Vaccine Administered |
0‑L | 69 | parainfluenza-3 virus vaccine | Vaccine Administered |
0‑L | 71 | respiratory syncytial virus immune globulin, intravenous | Vaccine Administered |
0‑L | 74 | rotavirus, live, tetravalent vaccine | Vaccine Administered |
0‑L | 75 | vaccinia (smallpox) vaccine | Vaccine Administered |
0‑L | 76 | Staphylococcus bacteriophage lysate | Vaccine Administered |
0‑L | 77 | tick-borne encephalitis vaccine | Vaccine Administered |
0‑L | 78 | tularemia vaccine | Vaccine Administered |
0‑L | 79 | vaccinia immune globulin | Vaccine Administered |
0‑L | 80 | Venezuelan equine encephalitis, live, attenuated | Vaccine Administered |
0‑L | 801 | AS03 Adjuvant | Vaccine Administered |
0‑L | 81 | Venezuelan equine encephalitis, inactivated | Vaccine Administered |
0‑L | 82 | adenovirus vaccine, unspecified formulation | Vaccine Administered |
0‑L | 83 | hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule | Vaccine Administered |
0‑L | 84 | hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule | Vaccine Administered |
0‑L | 85 | hepatitis A vaccine, unspecified formulation | Vaccine Administered |
0‑L | 86 | immune globulin, intramuscular | Vaccine Administered |
0‑L | 87 | immune globulin, intravenous | Vaccine Administered |
0‑L | 88 | influenza virus vaccine, unspecified formulation | Vaccine Administered |
0‑L | 89 | poliovirus vaccine, unspecified formulation | Vaccine Administered |
0‑L | 90 | rabies vaccine, unspecified formulation | Vaccine Administered |
0‑L | 91 | typhoid vaccine, unspecified formulation | Vaccine Administered |
0‑L | 92 | Venezuelan equine encephalitis vaccine, unspecified formulation | Vaccine Administered |
0‑L | 93 | respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular | Vaccine Administered |
0‑L | 94 | measles, mumps, rubella, and varicella virus vaccine | Vaccine Administered |
0‑L | 95 | tuberculin skin test; old tuberculin, multipuncture device | Vaccine Administered |
0‑L | 96 | tuberculin skin test; purified protein derivative solution, intradermal | Vaccine Administered |
0‑L | 97 | tuberculin skin test; purified protein derivative, multipuncture device | Vaccine Administered |
0‑L | 98 | tuberculin skin test; unspecified formulation | Vaccine Administered |
0‑L | 998 | no vaccine administered | Vaccine Administered |
|